Daniel Cotter recently authored an article published in the Chicago Daily Law Bulletin, “Justices sound skeptical of claim over mifepristone, FDA actions.”
Want to get our alerts?
Click “Subscribe Now” to get attorney insights on the latest developments in a range of services and industries.
Daniel Cotter recently authored an article published in the Chicago Daily Law Bulletin, “Justices sound skeptical of claim over mifepristone, FDA actions.” Daniel gives insight into the Food and Drug Administration's actions related to mifepristone. “We will see what the court does, but it appears the justices will side with the IRS and include such proceeds. These issues likely have no answers in the text of the statutes or the language of the Constitution,” says Daniel. To read more, click here.
